Pot stocks have had a rough few months, and shareholders of Tilray have been hit especially hard as shares have dropped 55% since early August. Much of that decline can be traced to disappointing earnings results. In mid-August, Tilray showed sales growth in Q2, as revenue jumped nearly 400%. However, management's aggressive spending produced net losses, and investors responded to the news by shedding shares.
Tuesday's earnings report will likely contain these same themes of high sales growth paired with soaring expenses. That means there's little reason to expect a dramatic shift in Tilray's stock-price trend - at least until investors get more concrete signs that point to the likelihood of sustainable earnings generation in this unproven industry.
The good news is that with shares battered so far in 2019, even a modest step toward profitability could spark a rally in the stock as early as this week.
Tuesday's earnings report will likely contain these same themes of high sales growth paired with soaring expenses. That means there's little reason to expect a dramatic shift in Tilray's stock-price trend - at least until investors get more concrete signs that point to the likelihood of sustainable earnings generation in this unproven industry.
The good news is that with shares battered so far in 2019, even a modest step toward profitability could spark a rally in the stock as early as this week.